All In MedTech

Device Trial Radar · NCT00707720

Multi-Center Feasibility Study of Trans-oral Endoscopic Restrictive Implant System (TERIS) for Treatment of Obesity

Multi-center Feasibility Study to Evaluate the Safety of the Trans-oral Endoscopic Restrictive Implant System (TERIS) for the Treatment of Obesity

Last checked: Nov 21, 2026Latest source record: Apr 10, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jun 2008

Primary completion

May 2011

Study completion Dec 2011

Sponsor

Lead sponsor
BaroSense Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 1, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Barosense Trans-oral Endoscopic Restrictive Implant System (TERIS) is an investigational system being evaluated for safety The system uses endoscopic guidance to trans-orally implant a restrictive reservoir for food entering the stomach in obese and morbidly obese subjects to induce early and prolonged satiety. The Intended Use of the system is for the treatment of obesity.

Conditions

  • Obesity

Interventions

  • TERIS procedureDevice

    The implantation of the restrictive implant

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse Events relating to the procedure and deviceTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hopital Laval

    Québec, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.